CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities:
Net income (loss)	$ 1,970	$ (578)	$ (330)
Adjustments to reconcile net income (loss) to net cash flows from operating activities:
Depreciation and amortization	1,087	1,061	1,105
(Gain) loss on business dispositions	(40)	451	0
(Gain) loss on equity securities	(555)	265	845
Stock-based compensation cost	197	207	205
Property, plant and equipment impairment, net	(1)	166	7
(Benefit) provision for deferred income taxes	(59)	105	133
Inventory impairment	35	31	0
Changes in operating assets and liabilities:
Current receivables	(986)	(625)	(126)
Inventories	(461)	(885)	170
Accounts payable	61	605	246
Progress collections and deferred income	1,639	1,103	(72)
Contract and other deferred assets	(211)	(76)	262
Other operating items, net	386	58	(71)
Net cash flows from operating activities	3,062	1,888	2,374
Cash flows from investing activities:
Expenditures for capital assets	(1,224)	(989)	(856)
Proceeds from disposal of assets	208	217	315
Proceeds from sale of equity securities	372	26	147
Proceeds from business dispositions	293	0	70
Net cash paid for acquisitions	(301)	(767)	(87)
Other investing items, net	(165)	(51)	(52)
Net cash flows used in investing activities	(817)	(1,564)	(463)
Cash flows from financing activities:
Repayment of long-term debt	(651)	0	(1,313)
Proceeds from the issuance of long-term debt	0	0	1,250
Repayment of commercial paper	0	0	(832)
Dividends paid	(786)	(726)	(592)
Repurchase of Class A common stock	(538)	(828)	(434)
Distributions to GE	0	(17)	(157)
Other financing items, net	(53)	(21)	(65)
Net cash flows used in financing activities	(2,028)	(1,592)	(2,143)
Effect of currency exchange rate changes on cash and cash equivalents	(59)	(97)	(47)
Increase (decrease) in cash and cash equivalents	158	(1,365)	(279)
Cash and cash equivalents, beginning of period	2,488	3,853	4,132
Cash and cash equivalents, end of period	$ 2,646	$ 2,488	$ 3,853